Published in Eur J Clin Pharmacol on September 25, 2007
The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature. J Am Med Inform Assoc (2012) 2.28
Electronic medication packaging devices and medication adherence: a systematic review. JAMA (2014) 1.12
What are validated self-report adherence scales really measuring?: a systematic review. Br J Clin Pharmacol (2014) 1.11
Physician effectiveness in interventions to improve cardiovascular medication adherence: a systematic review. J Gen Intern Med (2010) 1.03
Adherence: a review of education, research, practice and policy in Switzerland. Pharm Pract (Granada) (2009) 0.94
Packaging interventions to increase medication adherence: systematic review and meta-analysis. Curr Med Res Opin (2014) 0.87
The Impact of Information Technology on Patient Engagement and Health Behavior Change: A Systematic Review of the Literature. JMIR Med Inform (2016) 0.86
A new electronic monitoring device to measure medication adherence: usability of the Helping Hand™. Sensors (Basel) (2010) 0.84
The effect of medical device dose-memory functions on patients' adherence to treatment, confidence, and disease self-management. Patient Prefer Adherence (2014) 0.80
A Comparison between The Effectiveness of Short Message Service and Reminder Cards Regarding Medication Adherence in Patients with Hypertension: A Randomized Controlled Clinical Trial. Int J Community Based Nurs Midwifery (2016) 0.78
Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care (2004) 12.32
How often is medication taken as prescribed? A novel assessment technique. JAMA (1989) 5.98
Helping patients follow prescribed treatment: clinical applications. JAMA (2002) 5.18
Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf (2006) 5.16
Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data. CMAJ (1999) 2.44
Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population. BMJ (1995) 2.10
Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. J Hypertens (2001) 1.80
The electronic medication event monitor. Lessons for pharmacotherapy. Clin Pharmacokinet (1997) 1.47
Screening for noncompliance among patients with hypertension: is self-report the best available measure? Med Care (1981) 1.37
Monitoring compliance in resistant hypertension: an important step in patient management. J Hypertens Suppl (2003) 1.28
Electronic monitoring of adherence to treatment in the preventive chemotherapy of tuberculosis. Int J Tuberc Lung Dis (1998) 1.07
Why Objective Monitoring of Compliance is Important in the Management of Hypertension. J Clin Hypertens (Greenwich) (2000) 0.92
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens (2009) 4.87
Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ (2008) 3.24
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet (2012) 3.04
Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet (2013) 2.92
Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population. Am J Kidney Dis (2010) 2.71
Nighttime blood pressure and nocturnal dipping are associated with daytime urinary sodium excretion in African subjects. Hypertension (2008) 2.46
Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data. Hypertension (2006) 2.46
Assessing the prevalence of hypertension in populations: are we doing it right? J Hypertens (2003) 2.35
Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension. PLoS Genet (2010) 2.24
Prevalence of hypertension in schoolchildren based on repeated measurements and association with overweight. J Hypertens (2007) 2.13
Step count is associated with lower nighttime systolic blood pressure and increased dipping. Am J Hypertens (2013) 2.00
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press (2009) 1.98
Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril. Hypertension (2002) 1.71
Independent relations of left ventricular structure with the 24-hour urinary excretion of sodium and aldosterone. Hypertension (2009) 1.69
Eligibility for renal denervation: experience at 11 European expert centers. Hypertension (2014) 1.68
Postischemic forearm skin reactive hyperemia is related to cardovascular risk factors in a healthy female population. J Hypertens (2002) 1.64
Genome-wide association analysis of blood-pressure traits in African-ancestry individuals reveals common associated genes in African and non-African populations. Am J Hum Genet (2013) 1.55
Potassium supplementation reduces cardiac and renal hypertrophy independent of blood pressure in DOCA/salt mice. Hypertension (2005) 1.46
Plasma aldosterone is independently associated with the metabolic syndrome. Hypertension (2006) 1.40
Defective ENaC processing and function in tissue kallikrein-deficient mice. J Biol Chem (2007) 1.40
Female sex hormones, salt, and blood pressure regulation. Am J Hypertens (2004) 1.33
Monitoring one-year compliance to antihypertension medication in the Seychelles. Bull World Health Organ (2002) 1.30
Referral patterns and outcomes in noncritically ill patients with hospital-acquired acute kidney injury. Clin J Am Soc Nephrol (2011) 1.27
Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials. J Am Heart Assoc (2014) 1.26
Association between arterial properties and renal sodium handling in a general population. Hypertension (2006) 1.24
CYP3A5 and ABCB1 genes influence blood pressure and response to treatment, and their effect is modified by salt. Hypertension (2007) 1.23
Glomerular hyperfiltration and increased proximal sodium reabsorption in subjects with type 2 diabetes or impaired fasting glucose in a population of the African region. Nephrol Dial Transplant (2010) 1.14
Heritability of renal function in hypertensive families of African descent in the Seychelles (Indian Ocean). Kidney Int (2005) 1.13
Ambulatory blood pressure monitoring to assess cardiovascular risk in women. Hypertension (2011) 1.11
Effects of the peroxisomal proliferator-activated receptor-gamma agonist pioglitazone on renal and hormonal responses to salt in healthy men. J Clin Endocrinol Metab (2004) 1.11
Oscillometric blood pressure reference values in children. J Hypertens (2013) 1.11
Reasons for not intensifying antihypertensive treatment (RIAT): a primary care antihypertensive intervention study. J Hypertens (2004) 1.11
Relationship between drug-related problems and health outcomes: a cross-sectional study among cardiovascular patients. Pharm World Sci (2010) 1.08
Blood pressure and renal sodium handling in relation to genetic variation in the DRD1 promoter and GRK4. Hypertension (2008) 1.08
Nutrition in cardiovascular disease: salt in hypertension and heart failure. Eur Heart J (2011) 1.06
An interdisciplinary HIV-adherence program combining motivational interviewing and electronic antiretroviral drug monitoring. AIDS Care (2011) 1.06
Impact of electronic monitoring of drug adherence on blood pressure control in primary care: a cluster 12-month randomised controlled study. Eur J Intern Med (2008) 1.05
Increased carotid intima-media thickness in the absence of atherosclerotic plaques in an adult population with Fabry disease. Acta Paediatr Suppl (2006) 1.04
Blood pressure, cardiac, and renal responses to salt and deoxycorticosterone acetate in mice: role of Renin genes. J Am Soc Nephrol (2002) 1.04
Assessing medication adherence: options to consider. Int J Clin Pharm (2013) 1.04
Haemodynamic consequences of changing bicarbonate and calcium concentrations in haemodialysis fluids. Nephrol Dial Transplant (2008) 1.03
Effect of sodium loading/depletion on renal oxygenation in young normotensive and hypertensive men. Hypertension (2010) 1.03
Do travelers really take their mefloquine malaria chemoprophylaxis? Estimation of adherence by an electronic pillbox. J Travel Med (2006) 1.02
Blood pressure control and the implementation of guidelines in clinical practice: can we fill the gap? J Hypertens (2002) 1.02
High heritability of ambulatory blood pressure in families of East African descent. Hypertension (2005) 1.02
Reference values and factors associated with renal resistive index in a family-based population study. Hypertension (2013) 1.00
Cardiac and vascular hypertrophy in Fabry disease: evidence for a new mechanism independent of blood pressure and glycosphingolipid deposition. Arterioscler Thromb Vasc Biol (2006) 1.00
The nine-year sustained cost-containment impact of swiss pilot physicians-pharmacists quality circles. Ann Pharmacother (2010) 1.00
Comparative angiotensin II receptor blockade in healthy volunteers: the importance of dosing. Clin Pharmacol Ther (2002) 0.98
Retracted Oxidized LDL modulates apoptosis of regulatory T cells in patients with ESRD. J Am Soc Nephrol (2009) 0.97
Relationships among endogenous ouabain, alpha-adducin polymorphisms and renal sodium handling in primary hypertension. J Hypertens (2008) 0.97
Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortality. AIDS (2015) 0.95
Hyperuricemia, hypertension, and proteinuria associated with high-altitude polycythemia. Am J Kidney Dis (2002) 0.93
Renal perfusion evaluation with contrast-enhanced ultrasonography. Nephrol Dial Transplant (2011) 0.93
Determination of cardiac contractility in awake unsedated mice with a fluid-filled catheter. Am J Physiol Heart Circ Physiol (2003) 0.93
Incidence, complications and risk factors for severe falls in patients on maintenance haemodialysis. Nephrol Dial Transplant (2011) 0.92
Citrate- vs. acetate-based dialysate in bicarbonate haemodialysis: consequences on haemodynamics, coagulation, acid-base status, and electrolytes. BMC Nephrol (2009) 0.92
Cardiac hypertrophy, low blood pressure, and low aldosterone levels in mice devoid of the three circadian PAR bZip transcription factors DBP, HLF, and TEF. Am J Physiol Regul Integr Comp Physiol (2010) 0.92
Heritability, determinants and reference values of renal length: a family-based population study. Eur Radiol (2013) 0.92
Why Objective Monitoring of Compliance is Important in the Management of Hypertension. J Clin Hypertens (Greenwich) (2000) 0.92
Anemia and chronic kidney disease are potential risk factors for mortality in stroke patients: a historic cohort study. BMC Nephrol (2010) 0.92
Not all inflammatory markers are linked to kidney function: results from a population-based study. Am J Nephrol (2012) 0.91
Calcium, vitamin D and cardiovascular disease. Kidney Blood Press Res (2011) 0.91
Prevalence of microalbuminuria in the general population of Seychelles and strong association with diabetes and hypertension independent of renal markers. J Hypertens (2008) 0.91
Antiretroviral adherence program in HIV patients: a feasibility study in the Swiss HIV Cohort Study. Pharm World Sci (2010) 0.90
Chronic hyperaldosteronism in a transgenic mouse model fails to induce cardiac remodeling and fibrosis under a normal-salt diet. Am J Physiol Renal Physiol (2004) 0.90
Patterns of adherence to raltegravir-based regimens and the risk of virological failure among HIV-infected patients: the RALTECAPS cohort study. J Acquir Immune Defic Syndr (2012) 0.89
Ethnic differences in proximal and distal tubular sodium reabsorption are heritable in black and white populations. J Hypertens (2009) 0.89
Adherence to antiretroviral treatment decreases during postpartum compared to pregnancy: a longitudinal electronic monitoring study. AIDS Patient Care STDS (2013) 0.89
Pegylated interferon for the treatment of hepatitis C virus in haemodialysis patients. Nephrol Dial Transplant (2005) 0.89
Swallowing difficulties with oral drugs among polypharmacy patients attending community pharmacies. Int J Clin Pharm (2013) 0.89
Calcium-sensing receptors modulate renin release in vivo and in vitro in the rat. J Hypertens (2009) 0.89
Blockade of the renin-angiotensin system and renal tissue oxygenation as measured with BOLD-MRI in patients with type 2 diabetes. Diabetes Res Clin Pract (2012) 0.88
Reactive rise in blood pressure upon cuff inflation: cuff inflation at the arm causes a greater rise in pressure than at the wrist in hypertensive patients. Blood Press Monit (2007) 0.88
Renal sodium handling in patients with normal pressure glaucoma. Clin Sci (Lond) (2007) 0.88
Microalbuminuria, but not cystatin C, is associated with carotid atherosclerosis in middle-aged adults. Nephrol Dial Transplant (2007) 0.88
Gonadal steroids, salt-sensitivity and renal function. Curr Opin Nephrol Hypertens (2007) 0.87
Residual effect of renal denervation in patients with truly resistant hypertension. Hypertension (2013) 0.87
Prevalence of obesity and overweight and associated nutritional factors in a population-based Swiss sample: an opportunity to analyze the impact of three different European cultural roots. Eur J Nutr (2013) 0.87
Pharmaceutical care in community pharmacies: practice and research in Switzerland. Ann Pharmacother (2006) 0.87
Anemia and chronic kidney disease are associated with poor outcomes in heart failure patients. BMC Nephrol (2006) 0.87
Renal tissue oxygenation in essential hypertension and chronic kidney disease. Int J Hypertens (2013) 0.86
Angiotensin II receptor blockade: is there truly a benefit of adding an ACE inhibitor? Hypertension (2003) 0.86
In vitro and in vivo characterization of the activity of telmisartan: an insurmountable angiotensin II receptor antagonist. J Pharmacol Exp Ther (2002) 0.86
Performance of blood pressure-to-height ratio at a single screening visit for the identification of hypertension in children. J Hypertens (2014) 0.85
A pregnant woman with de novo polyuria-polydipsia and elevated liver enzymes. Nephrol Dial Transplant (2003) 0.85
No use for waist-for-height ratio in addition to body mass index to identify children with elevated blood pressure. Blood Press (2012) 0.85
Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence. J Hypertens (2014) 0.85
Determinants and burden of chronic kidney disease in the population-based CoLaus study: a cross-sectional analysis. Nephrol Dial Transplant (2013) 0.84
Renal hemodynamic and tubular responses to salt in women using oral contraceptives. Kidney Int (2003) 0.84
Hyperresponders vs. nonresponder patients after renal denervation: do they differ? J Hypertens (2014) 0.84